Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Model wear the breast cancer awareness pink ribbon Hannah Marsh/John Birdsall/Press Association Images
Breast Cancer

'Breakthrough' breast cancer test to be made available to public

The genetic test can accurately identify the patients who remain at risk following surgery for breast cancer – determining who would benefit from chemotherapy.

A NEW TEST for breast cancer, which has been hailed as a “breakthrough” by experts, is to be offered to all public patients who require it.

The Oncotype DX genetic test can accurately identify the patients who remain at risk following surgery for breast cancer, thereby determining which patients would benefit from chemotherapy.

It is estimated that the test could benefit as many as 500 women in Ireland each year.

The test was initially deemed too expensive to be made publicly available by the National Centre for Pharmacoeconomics, however doctors argued that it could save money in the long-term as it would reduce the number of people seeking chemotherapy.

RTÉ reports that the test will be made available to public patients from this week.

Read: ‘Breakthrough’ cancer test will not be offered to public patients>

Your Voice
Readers Comments
2
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.